Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence

Abstract To investigate the frequency of monocytic myeloid-derived suppressor cells (M-MDSCs) in type 2 diabetes mellitus (T2DM) patients and explore the potential associations between M-MDSCs, glycemic control, and the occurrence of infections and tumor. 102 healthy and 77 T2DM individuals were enr...

Full description

Bibliographic Details
Main Authors: Ji Zhou, Mengjie Zhang, Xiaodi Ju, Huiping Wang, Hao Xiao, Zhimin Zhai, Xing Zhong, Jingfang Hong
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-54496-w
_version_ 1797274760194818048
author Ji Zhou
Mengjie Zhang
Xiaodi Ju
Huiping Wang
Hao Xiao
Zhimin Zhai
Xing Zhong
Jingfang Hong
author_facet Ji Zhou
Mengjie Zhang
Xiaodi Ju
Huiping Wang
Hao Xiao
Zhimin Zhai
Xing Zhong
Jingfang Hong
author_sort Ji Zhou
collection DOAJ
description Abstract To investigate the frequency of monocytic myeloid-derived suppressor cells (M-MDSCs) in type 2 diabetes mellitus (T2DM) patients and explore the potential associations between M-MDSCs, glycemic control, and the occurrence of infections and tumor. 102 healthy and 77 T2DM individuals were enrolled. We assessed the M-MDSCs frequency, levels of fasting plasma glucose (FPG), haemoglobin A1c (HbA1c), and other relevant indicators. Each patient underwent a follow-up of at least 6 months after M-MDSCs detection. The M-MDSCs frequency was significantly higher in patients with poor glycemic control (PGC) compared to the healthy population (P < 0.001), whereas there was no significant difference between patients with good glycemic control and the healthy (P > 0.05). There was a positive correlation between the M-MDSCs frequency and FPG, HbA1c (R = 0.517 and 0.315, P < 0.001, respectively). T2DM patients with abnormally increased M-MDSCs have a higher incidence of infection and tumor (48.57% and 11.43% respectively). Our results shed new light on the pathogenesis of T2DM, help to understand why T2DM patients are susceptible to infection and tumor and providing novel insights for future prevention and treatment of T2DM.
first_indexed 2024-03-07T15:02:54Z
format Article
id doaj.art-f82b15c932f440c19338a4a39946aa2f
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-07T15:02:54Z
publishDate 2024-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-f82b15c932f440c19338a4a39946aa2f2024-03-05T19:03:36ZengNature PortfolioScientific Reports2045-23222024-02-0114111010.1038/s41598-024-54496-wIncreased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrenceJi Zhou0Mengjie Zhang1Xiaodi Ju2Huiping Wang3Hao Xiao4Zhimin Zhai5Xing Zhong6Jingfang Hong7Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical UniversityDepartment of Endocrinology, The Second Affiliated Hospital of Anhui Medical UniversitySchool of Nursing, Anhui Medical UniversityHematologic Department/Hematologic Disease Research Center, the Second Affiliated Hospital of Anhui Medical UniversityHematologic Department/Hematologic Disease Research Center, the Second Affiliated Hospital of Anhui Medical UniversityHematologic Department/Hematologic Disease Research Center, the Second Affiliated Hospital of Anhui Medical UniversityDepartment of Endocrinology, The Second Affiliated Hospital of Anhui Medical UniversitySchool of Nursing, Anhui Medical UniversityAbstract To investigate the frequency of monocytic myeloid-derived suppressor cells (M-MDSCs) in type 2 diabetes mellitus (T2DM) patients and explore the potential associations between M-MDSCs, glycemic control, and the occurrence of infections and tumor. 102 healthy and 77 T2DM individuals were enrolled. We assessed the M-MDSCs frequency, levels of fasting plasma glucose (FPG), haemoglobin A1c (HbA1c), and other relevant indicators. Each patient underwent a follow-up of at least 6 months after M-MDSCs detection. The M-MDSCs frequency was significantly higher in patients with poor glycemic control (PGC) compared to the healthy population (P < 0.001), whereas there was no significant difference between patients with good glycemic control and the healthy (P > 0.05). There was a positive correlation between the M-MDSCs frequency and FPG, HbA1c (R = 0.517 and 0.315, P < 0.001, respectively). T2DM patients with abnormally increased M-MDSCs have a higher incidence of infection and tumor (48.57% and 11.43% respectively). Our results shed new light on the pathogenesis of T2DM, help to understand why T2DM patients are susceptible to infection and tumor and providing novel insights for future prevention and treatment of T2DM.https://doi.org/10.1038/s41598-024-54496-w
spellingShingle Ji Zhou
Mengjie Zhang
Xiaodi Ju
Huiping Wang
Hao Xiao
Zhimin Zhai
Xing Zhong
Jingfang Hong
Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence
Scientific Reports
title Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence
title_full Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence
title_fullStr Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence
title_full_unstemmed Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence
title_short Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence
title_sort increased monocytic myeloid derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence
url https://doi.org/10.1038/s41598-024-54496-w
work_keys_str_mv AT jizhou increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence
AT mengjiezhang increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence
AT xiaodiju increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence
AT huipingwang increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence
AT haoxiao increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence
AT zhiminzhai increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence
AT xingzhong increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence
AT jingfanghong increasedmonocyticmyeloidderivedsuppressorcellsintype2diabetescorrelatewithhyperglycemicandwasariskfactorofinfectionandtumoroccurrence